1. Introduction {#sec1}
===============

Coronary artery disease (CAD) is a common cause of morbidity and mortality Worldwide \[[@B1]\]. Medical therapy and interventional or surgical techniques seem to save lots of patients with acute myocardial infarction in emergency phrase. However, long term outcomes remain unsatisfactory \[[@B2]\]. Thus further understanding of the etiology may provide potential diagnosis and therapeutic method for CAD. Recently, many reports present that epicardial adipose tissue (EAT) plays an important role in the progression of many disease by secretion various bioactive molecules \[[@B3]\]. In addition, finding also shows that the changing state of EAT will significantly affect the cardiac function and increase cardiovascular risk in human beings \[[@B4], [@B5]\].

CAD is a kind of coronary artery disease and most studies aim to research through the blood sample. However, EAT is found to have relevant with the heart because it is a type of visceral fat depot. The EAT widely distributes between the pericardium and myocardium which serves with metabolically activation \[[@B6]\]. Owing to its special location and close proximity to coronary vasculature, comparison of different express gene between EAT\[[@B7]\] and subcutaneous adipose tissue (SAT) may provide important information about the state of the coronary artery and maybe have potential for diagnosis and therapy for human CAD.

mRNAs have been reported to participate in the regulation of pathophysiological conditions of cardiovascular disease (CVD) \[[@B8]\]. However, the existing results of mRNAs profiles of CAD can not identify the core pathogenic genes and the potential molecular mechanisms of human CAD \[[@B9]--[@B11]\]. Therefore, we downloaded the two mRNAs profiles data and screened out the co-expression differentially expressed genes (DEGs) between GSE 18612 and GSE 64554. After analyzing by biomathematical online tools and software, 10 hub genes were finally identified which could serve as new biomarkers and therapeutic targets for human CAD.

2. Materials and Methods {#sec2}
========================

2.1. Microarray Analysis {#sec2.1}
------------------------

This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Second Hospital of Jilin University. The two mRNA profiles were searched by CAD and EAT as well as human in gene expression omnibus (GEO) database (<http://www.ncbi.nlm.nih.gov/geo>). All the data were provided from GPL96 platform. GSE 18612 contained 7 EAT from CAD patients and 6 SAT from noncoronary artery disease (NC) and there were 13 EAT from CAD patients and 10 SAT from NC patients in GSE 64554. All the data were analyzed with GEO2R online tool with two classifications including EAT and SAT.

2.2. Data Processing and Identifcation of DEGs {#sec2.2}
----------------------------------------------

Downregulated and upregulated genes were selected in each profile with *p* \< 0.05 and fold change \>1.2 or \< −1.2. *R* sofware including affy package \[[@B12]\]and limma package \[[@B13]\] were used to identify the final co-expression DEGs.

2.3. Gene Ontology and Pathway Enrichment Analyses {#sec2.3}
--------------------------------------------------

All DEGs and hub genes as well as predict genes in Molecular Complex Detection (MCODE) were analysis by DAVID (the Database for Annotation, Visualization, and Integrated Discovery) online bio-informatics database \[[@B14]\]. Gene ontology (GO) enrichment including cellular component (CC), biological processes (BP) and molecular function (MF) were acquired from DAVID. Pathway analysis of all DEGs was analysised by KEGG pathways tool. All the results were selected with gene count \>2 and *p* \< 0.05.

2.4. Integration of Protein-Protein Interaction (PPI) Network Analysis {#sec2.4}
----------------------------------------------------------------------

The DEGs were totally typed into STRING (<https://string-db.org/cgi/input.pl>) database \[[@B15]\] to get PPI networks and the interaction data among all co-expression genes were picked with a significant confidence score \>0.9. Then the interaction data were typed into the Cytoscape software \[[@B16]\] to structure a PPI network. Based on the above data, we used MCODE \[[@B17]\], a built-in APP in Cytoscape software, to analyze the interactive relationship of the DEGs encoding proteins and screen hub gene. The parameters of network scoring and cluster finding were set as follows: find clusters = in whole network, degree cutoff = 2, cluster finding = haircut, node score cutoff = 0.2, k-core = 2, and max depth = 100. The parameters of cytoHubba were set as follows: Hubba nodes = top 10 nodes ranked by degree, display options = check the first-stage nodes, display the shortest path and display the expanded sub network.

2.5. Quantitative Reverse Transcription-PCR (qRT-PCR) Validation and Statistical Analysis {#sec2.5}
-----------------------------------------------------------------------------------------

qRT-PCR was used to verify the top 10 hug genes. PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa, Japan) was used to provide the process of RNA reverse-transcribed to cDNA. Primers were designed from Primer-BLAST (<https://www.ncbi.nlm.nih.gov/tools/primer-blast>) and listed in [Table 1](#tab1){ref-type="table"}. QuantStudio 7 Flex real-time PCR system (Applied Biosystems, Carlsbad, CA, USA) was used \[[@B18], [@B19]\] and samples were normalized to GAPDH. All the operations were according to the manufacturer\'s instructions. The relative expression levels of each gene were calculated using 2^−ΔΔCt^ methods.

3. Results {#sec3}
==========

3.1. Identification of DEGs in the CAD and NC Groups {#sec3.1}
----------------------------------------------------

All of 20 EAT from CAD patients and 16 SAT from NC patients were analyzed with *R* software with a threshold setting at *p* \< 0.05 and fold change \>1.2. There were 2617 and 2192 DEGs in GSE 18612 and GSE 64554 mRNAs profiles, respectively. Finally, all 179 co-expression DEGs were selected through integrating analysis, which included 105 downregulated and 74 upregulated DEGs in EAT from CAD samples.

3.2. GO Functional Enrichment Analysis {#sec3.2}
--------------------------------------

All DEGs including downregulated and upregulated co-expression genes were typed into DAVID online tool respectively. The functions of GO analysis were divided into three classifications: BP, CC, and MF ([Figure 1](#fig1){ref-type="fig"}). As shown in [Figure 1](#fig1){ref-type="fig"} and [Table 2](#tab2){ref-type="table"}, in the biological processes group, the upregulated DEGs were mainly enriched in B cell receptor signaling pathway, cellular response to drug, adaptive immune response, inflammatory response, and negative regulation of protein phosphorylation, and the downregulated DEGs were mainly enriched in collagen catabolic process, cellular response to amino acid stimulus, endodermal cell differentiation and cell proliferation. In the cellular component group, the upregulated DEGs were mainly enriched in plasma membrane, cytosol, extracellular space, anchored component of membrane and extracellular region, and the downregulated DEGs were mainly enriched in extracellular matrix, extracellular exosome, protein complex, cytoplasm and cell-cell adherens junction. In the molecular function group, the upregulated DEGs were mainly enriched in identical protein binding, copper ion binding, protein complex binding, integrin binding and G-protein alpha-subunit binding, and the downregulated DEGs were mainly enriched in Rho GDP-dissociation inhibitor binding, ubiquitin protein ligase binding, cadherin binding involved in cell-cell adhesion, protein domain specific binding and lipoprotein lipase activity.

3.3. Signaling Pathway Analysis {#sec3.3}
-------------------------------

KEGG pathway analysis on DAVID online tool indicated that upregulated genes were mainly enriched in HIF-1 signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Salmonella infection and NF-kappa B signaling pathway. The downregulated genes were mainly enriched in Focal adhesion, Proteoglycans in cancer, PI3K-Akt signaling pathway, Ras signaling pathway, and Neurotrophin signaling pathway ([Figure 2](#fig2){ref-type="fig"}).

3.4. PPI Network and Modular Analysis {#sec3.4}
-------------------------------------

STRING database presented a result with 178 nodes and 363 edges ([Figure 3](#fig3){ref-type="fig"}) after analysis of all the DEGs. The nodes and edges were put into the cytoscape software in order to acquire a PPI network. CytoHubba analysis section showed 10 hub genes, including AKT1, MYC, EGFR, ACTB, CDC42, IGF1, FGF2, CXCR4, MMP2, and LYN after degree calculation. In these 10 hub genes, AKT1 presented with the highest degree (degree = 38). The cytoscape plugin MCODE showed the top three modules with scores of 11.429, 3.333, and 3.000 ([Figure 4](#fig4){ref-type="fig"}). MCODE 1 contained 15 nodes including IL1B, AKT1, ANGPT2, MYC, LYN, FGF2, EGFR, TFRC, AR, ACTB, MMP2, IGF1, CDC42, CXCR4, and ANGPT1 with 80 edges. Then, all the 15 prediction genes in module 1 were analyzed by GO and KEGG analysis, which mainly aimed to Focal adhesion, MAPK signaling pathway, Salmonella infection, Adherens junction and Regulation of actin cytoskeleton. Module 2 was mainly associated with the Ubiquitin mediated proteolysis and Protein processing in endoplasmic reticulum. Module 3 was mainly associated with Protein digestion and absorption, ECM-receptor interaction, Focal adhesion and PI3K-Akt signaling pathway.

All the top 10 hub gene were verified by qRT-PCR which presented that AKT1, EGFR, CDC42, FGF2 and MMP2 were significantly decreased in EAT of CAD samples (*p* \< 0.05) and MYC, ACTB, IGF1, CXCR4, and LYN were significantly increased (*p* \< 0.05) ([Figure 5](#fig5){ref-type="fig"}). All validation data were consistent with the microarray data and analytical results in this study.

4. Discussion {#sec4}
=============

Adipose tissue has been thought to act as an endocrine organ to participate and regulate the inflammatory process of CVD through paracrine or endocrine pathway. Recent research points that EAT, an atypical fat depot surrounding the heart, plays essential roles in CAD not only highly metabolic paracrine and endocrine functions, but also by its blood supply from coronary circulation \[[@B20]\]. Therefore some changes of EAT may directly indicate the different state of the heart as they supplies from the same coronary blood. In the meantime, studies have points that metabolic function of EAT may participate the initiation and progression of atherosclerosis \[[@B21]\]. So researching on the EAT can be able to provide a promising therapeutic target for the treatment of CVD including atherosclerosis.

With the fast development of sequencing technology, finding the changing genes between disease and normal tissue has become convenient. Up to now, there are many mRNAs profiles have been carried out and a lot of different genes have been detected between EAT and SAT from CAD patients \[[@B9]--[@B11]\]. mRNAs act as protein-coding genes, are believed to play an important role on modulating the metabolic function of adipose tissue and CAD. However, the initially change and the core pathogenic gene of CAD are not identified and the key pathogenesis of CAD has not been confirmed until now.

As different expression profiles of CAD provided various results with each other, we integrated the mRNAs profiles and analysised the co-expression DEGs. In this study, 105 downregulated DEGs and 74 upregulated DEGs were identified after integrating profile datasets. Similar to other studies \[[@B22], [@B23]\], these DEGs were dealt with GO and pathway analysis and a lot of KEGG pathways were found. However, the hub gene in CAD and the most relevant pathway and mechanism of CAD could not be identified. Therefore, we used more bioinformation tools such as PPI Network online tool, cytoscape analysis with cytoHubba and MCODE analysis for further analyses. The cytoHubba analysis showed that the top ten hub genes were AKT1, MYC, EGFR, ACTB, CDC42, IGF1, FGF2, CXCR4, MMP2, and LYN. DAVID on line analysis tool predicted that these genes were highly relevant with the focal adhesion pathway in CAD. In addition, the MCODE provided another analysis of these DEGs. The top 1 MCODE contained 15 nodes including IL1B, AKT1, ANGPT2, MYC, LYN, FGF2, EGFR, TFRC, AR, ACTB, MMP2, IGF1, CDC42, CXCR4, ANGPT1 and 80 edges. These 15 nodes also indicated that Focal adhesion might act as the most relevant pathway after analysis by DAVID. Even better, the predicted genes in top 1 MCODE also contained all the top 10 hug genes. Therefore, we aimed to analyze the hub gene AKT1 and the Focal adhesion in CAD.

Akt kinase has been identified as one of the member of AGC kinases (AMP/GMP kinase and PKC subfamily of proteins), which is reported to play an important role in cell proliferation, migration and growth \[[@B24]\]. Although Akt1, Akt2, and Akt3 are the 3 isoforms of Akt, they play different functions in various cell environment. Recent study shows that Akt acts critical roles in the CVD including atherosclerosis \[[@B25]\]. The reduction of endothelial cell migration was found when Akt phosphorylation influenced by oxidized low density lipoprotein (LDL) \[[@B26]\]. In addition, inhibition of Akt in macrophages was also presented with reducing atherosclerosis \[[@B27]\]through decreasing in proinflammation and immune cell migration. Recent study also presented that inhibition of vascular endothelial growth factor (VEGF) through inducing Akt phosphorylation pathway might protect arteries from atherosclerosis through changing the peroxisome proliferator-activated receptors (PPARs). Therefore, the toppest hub gene Akt was believed to serve as a hub gene in the initial and progressive pathological in atherosclerosis.

Akt has been reported to activate or over expression with focal adhesion kinase (FAK) pathway signal. Reports show that interaction between FAK and Akt1 is found in many cancers. This interaction is always needed for subsequent FAK autophosphorylation, activation, and translocation to the focal adhesion complex (FAC) \[[@B28]\]. FAK was reported to participate in regulating cell adhesion, mobility and proliferation during many cell process. The focal adhesion signaling had provided insight into the role of FAK in cardiomyocyte signal transduction and had been reported to contribute to myocardial remodeling and the progression to heart failure \[[@B29]\]. In addition, FAK was also reported taking part in regulating the function of endothelial barrier \[[@B30]\]. Low expression of FAK in endothelial cells would result in formation of a tighter endothelial monolayer through raising cell attachment and connection. In addition, disruption of FAC would also lead to Ado/HC-induced endothelial apoptosis \[[@B31]\] and lipid would deposition following endothelial cell damage. Study also pointed that FAK played a role in reduction of lipopolysaccharide-induced inflammation injury through inactivation of the Wnt and NF-kappaB pathways \[[@B32]\] and inflammation injury was also an important factor during CAD. So focal adhesion signaling might act an important role in vascular endothelial dysfunction and pro-inflammatory reactions, and might be a core change during CAD.

In summary, by integration of different high-throughput sequencing profiles and data processing as well as hub genes, these genes may have the potential to be used as drug targets and diagnostic markers of CAD. The focal adhesion maybe the key pathway in CAD. However, there are still some limitations: further experimental studies with larger sample sizes are needed to confirm the role of the focal adhesion pathway in CAD.

This work was supported by the project supported by the Bethune Medical Department Doctoral Postgraduate Excellent Talents Training Program Project of Jilin Province, China (Grant no. 20181201), the Project of Direct Health Project of Jilin Provincial, China (Grant no. 20170101), and Project of Direct Health Project of Jilin Provincial, China (Grant no. 20180101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

CAD:

:   Coronary artery disease

EAT:

:   Epicardial adipose tissue

SAT:

:   Subcutaneous adipose tissue

DEGs:

:   The differentially expressed genes

GEO:

:   The gene expression omnibus

NC:

:   Noncoronary artery disease

GO:

:   Gene ontology;

KEGG:

:   Kyoto encyclopedia of genes and genomes

CC:

:   Cellular component

BP:

:   Biological processes

MF:

:   Molecular function

PPI:

:   Protein-protein interaction

MCODE:

:   Molecular complex detection

qRT-PCR:

:   Quantitative reverse transcription-PCR

CVD:

:   Cardiovascular disease

AGC kinases:

:   AMP/GMP kinase and PKC subfamily of proteins

LDL:

:   Low density lipoprotein

VEGF:

:   Vascular endothelial growth factor

PPARs:

:   Peroxisome proliferator-activated receptors

FAK:

:   Focal adhesion kinase

FAC:

:   Focal adhesion complexes

SDF1:

:   Stromal derived factor 1

EPCs:

:   Endothelial progenitor cells

GHSR:

:   Growth hormone secretagogue receptor.

Data Availability
=================

The data used to support the findings of this study are available from the corresponding author upon request.

Additional Points
=================

The elements in the manuscript have not been published or are under consideration for publication elsewhere.

Conflicts of Interest
=====================

The authors declare no competing financial and/or non financial interests in relation to the work described.

Authors\' Contributions
=======================

W.T.W, Q.L, B.L, H.L.P, Q.L, and Y.W wrote the paper. Z.C.Z, D.L, T.C.W, R.H.X, and K.X.L checked the References. All authors reviewed the final manuscript.

![Gene Ontology analysis classified the differentially expressed genes into 3 groups:molecular function, biological process, and cellular component.](BMRI2019-8567306.001){#fig1}

![Kyoto encyclopedia of genes and genomes enrichment analysis of the pathways. The gradual color represents the *P* value; the size of the black spots represents the gene number.](BMRI2019-8567306.002){#fig2}

![PPI network constructed with the differentially expressed genes. Blue nodes represent upregulated genes, purple nodes represent downregulated gene.](BMRI2019-8567306.003){#fig3}

![The top 10 hug gene analysis by cytoHubba (a). The gradual color represents the degree score. The most significance modules (b). Red nodes represent hug gene analysis by cytoHubba.](BMRI2019-8567306.004){#fig4}

![Validation of the mRNA microarray results by real-time qPCR. mRNA microarray results were verified by real-time qPCR between the CAD group (*n* = 10) and the control group (*n* = 10). All samples were normalized to the expression of GAPDH, and the relative expression levels of each gene were analyzed using the 2^−Δ\ Δ\ Ct^method. ^*∗*^*P* \< 0.05, ^*∗∗*^*P* \< 0.01.](BMRI2019-8567306.005){#fig5}

###### 

The primers of the top 10 hub genes.

  Gene name   Forward primer            Reverse primer
  ----------- ------------------------- -------------------------
  AKT1        AGCGACGTGGCTATTGTGAAG     GCCATCATTCTTGAGGAGGAAGT
  MYC         GGCTCCTGGCAAAAGGTCA       CTGCGTAGTTGTGCTGATGT
  EGFR        AGGCACGAGTAACAAGCTCAC     ATGAGGACATAACCAGCCACC
  ACTB        CATGTACGTTGCTATCCAGGC     CTCCTTAATGTCACGCACGAT
  CDC42       CCATCGGAATATGTACCGACTG    CTCAGCGGTCGTAATCTGTCA
  IGF1        GCTCTTCAGTTCGTGTGTGGA     GCCTCCTTAGATCACAGCTCC
  FGF2        AGAAGAGCGACCCTCACATCA     CGGTTAGCACACACTCCTTTG
  CXCR4       ACTACACCGAGGAAATGGGCT     CCCACAATGCCAGTTAAGAAGA
  MMP2        TACAGGATCATTGGCTACACACC   GGTCACATCGCTCCAGACT
  LYN         GCTTTTGGCACCAGGAAATAGC    TCATGTCGCTGATACAGGGAA
  GAPDH       CGGACCAATACGACCAAATCCG    AGCCACATCGCTCAGACACC

###### 

The significantly enriched analysis of differentially expressed genes in coronary artery disease.

  Expression   Category                                          Term                                Description   Gene count   *P*-value
  ------------ ------------------------------------------------- ----------------------------------- ------------- ------------ -----------
  UP-DEGs      BP                                                B cell receptor signaling pathway   GO:0050853    6            2.74E-06
  BP           Adaptive immune response                          GO:0002250                          6             3.55E-04     
  BP           GO:inflammatory response                          GO:0006954                          8             9.15E-04     
  BP           Negative regulation of protein phosphorylation    GO:0001933                          4             2.02E-03     
  BP           Lipopolysaccharide-mediated signaling pathway     GO:0031663                          3             7.62E-03     
  CC           Plasma membrane                                   GO:0005886                          35            5.28E-06     
  CC           Cytosol                                           GO:0005829                          26            7.67E-04     
  CC           Extracellular space                               GO:0005615                          14            2.47E-03     
  CC           Anchored component of membrane                    GO:0031225                          4             1.05E-02     
  CC           Extracellular region                              GO:0005576                          13            2.56E-02     
  MF           Identical protein binding                         GO:0042802                          10            2.44E-03     
  MF           Copper ion binding                                GO:0005507                          3             2.02E-02     
  MF           Protein complex binding                           GO:0032403                          4             4.68E-02     
  MF           Integrin binding                                  GO:0005178                          3             6.36E-02     
  MF           G-protein alpha-subunit binding                   GO:0001965                          2             7.18E-02     
  DOWN-DEGs    BP                                                Collagen catabolic process          GO:0030574    6            3.55E-05
  BP           GO:cellular response to amino acid stimulus       GO:0071230                          5             1.60E-04     
  BP           Endodermal cell differentiation                   GO:0035987                          4             5.09E-04     
  BP           Cell proliferation                                GO:0008283                          9             1.35E-03     
  BP           Receptor-mediated endocytosis                     GO:0006898                          6             4.68E-03     
  CC           Extracellular matrix                              GO:0031012                          10            3.94E-05     
  CC           Extracellular exosome                             GO:0070062                          29            1.09E-03     
  CC           Protein complex                                   GO:0043234                          7             2.71E-02     
  CC           Cytoplasm                                         GO:0005737                          39            3.18E-02     
  CC           Cell-cell adherens junction                       GO:0005913                          6             3.39E-02     
  MF           Rho GDP-dissociation inhibitor binding            GO:0051022                          2             2.21E-02     
  MF           Ubiquitin protein ligase binding                  GO:0031625                          6             2.21E-02     
  MF           Cadherin binding involved in cell-cell adhesion   GO:0098641                          6             2.30E-02     
  MF           Protein domain specific binding                   GO:0019904                          5             2.89E-02     
  MF           Lipoprotein lipase activity                       GO:0004465                          2             4.37E-02     
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